Join the Breast Cancer group to help and get support from people like you.
Breast Cancer News (Page 3)
Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS
Breast Cancer A Killer In Poor Countries, Report Says
TUESDAY, Feb. 25, 2025 – Breast cancer deaths are expected to increase during the next quarter-century, largely impacting the world’s poorest nations, a new international study says. About 1.1 m...
Women Of Color Receive Slower Response To A Bad Mammogram
WEDNESDAY, Feb. 19, 2025 – Women of color are less likely to receive prompt follow-up testing after abnormal mammogram results, a new study has found. Minority women are less likely than white women...
Minority Groups Less Likely to Receive Diagnostic Services After Abnormal Mammogram
WEDNESDAY, Feb. 19, 2025 – For patients after screening mammography, onsite availability of most diagnostic services is similar across race and ethnicity groups, but minority groups are less likely...
What Cancer Screenings Do You Need? A Quick Guide
SATURDAY, Feb. 15, 2025 – Cancer screenings can save lives by detecting cancer early, when treatment is most effective. With an estimated 2 million new cancer cases expected in 2025, regular...
American Cancer Society Calls for Restoration of Key CDC, FDA Data
FRIDAY, Feb. 14, 2025 – With certain government data currently being withheld, removed, or restored but partially redacted on the websites of the U.S. Centers for Disease Control and Prevention and...
AI Contributes to Early Detection of Clinically Relevant Breast Cancer
THURSDAY, Feb. 13, 2025 – Artificial intelligence (AI) contributes to early detection of clinically relevant breast cancer, according to a study published online Feb. 3 in The Lancet Digital Health....
Breast Cancer: Fear of Recurrence Can Haunt Women for Years
MONDAY, Feb. 10, 2025 – A survey of hundreds of breast cancer survivors finds that tumor recurrence fear can wreak havoc on a woman's emotions. “Cancer is all around us. Everything is a trigger," o...
Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers
FRIDAY, Feb. 7, 2025 – Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new phase 3 trial finds. The study involved patients with...
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
THURSDAY, Feb. 6, 2025 – For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding...
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
MONDAY, Feb. 3, 2025 – The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor ...
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic, hormone receptor (HR)-positive, ...
Enhertu Approved as First HER2-Directed Therapy for Patients with HER2-Low or HER2-Ultralow Metastatic Breast Cancer
27 January 2025 – AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (...
FDA Approves Datroway (datopotamab deruxtecan-dlnk) for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
WILMINGTON, Del.-- January 17, 2025 – Datroway (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor...
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
THURSDAY, Jan. 16, 2025 – For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab emtansine (T-DM1) improves overall survival more than...
AI-Supported Double Mammogram Reading Improves Detection Rate
TUESDAY, Jan. 14, 2025 – Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection rate, without affecting the recall rate, compared with...
Further information
Related condition support groups
Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Male, Cancer
Related drug support groups
methotrexate, fluorouracil, anastrozole, letrozole, Arimidex, Herceptin, Keytruda, Femara, tamoxifen, trastuzumab, Ibrance